Top compounds associated with response to LXN


Feature Type Standardized
Nominal ANOVA
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.01 0.8
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.01 0.8
mRNA simvastatin CTRPv2 pan-cancer AAC -0.011 0.8
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.01 0.8
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.0092 0.8
mRNA Pazopanib GDSC1000 pan-cancer AAC 0.01 0.8
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.0093 0.8
mRNA lapatinib CTRPv2 pan-cancer AAC 0.0098 0.8
mRNA UNC1215 GDSC1000 pan-cancer AAC 0.01 0.8
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.013 0.8
Download CSV